I am pleased to invite you to an educational dinner meeting focused on the management of overactive bladder symptoms and menopause-related vasomotor symptoms in women.

We are delighted to welcome Dr Monika Trivedi MBBS, MS (Obstetrics & Gynaecology), FRCOG (UK), FRANZCOG as our guest speaker. Dr Monika Trivedi is a highly qualified Obstetrician and Gynaecologist and minimally invasive surgeon with over 15 years of extensive experience, including 8 years in the Australian public and private sector. She has special interest in chronic pelvic pain, vulval disorders & minimally invasive urgeries. Please see topic details below.

Lower urinary tract symptoms (LUTS) in females: This module discusses urge and frequency symptoms in females in
younger age groups, in which pharmacological management may not be considered. The module uses case vignettes to illustrate how and when to ask about urinary urge and frequency at key time points. The role of Betmiga is discussed alongside other management strategies relevant at different life stages. 

Managing Menopause & VMS: This module reviews the epidemiology and burden of menopause-related vasomotor symptoms (VMS), highlighting menopausal therapy options and menopausal guideline management structures currently in place. The module then explores the pathophysiology of vasomotor symptoms in menopause and treatment option fezolinetant (Veoza). The efficacy, mode of action, safety profile, testing recommendations and contraindications are discussed in detail.